Specific Interventions - Pharmacologic

Thursday, May 15, 2014: 5:30 PM-7:00 PM
Atrium Ballroom (Marriott Marquis Atlanta)
5:30 PM
125.187
187 A Pilot, Open-Label Study of Pregnenolone in the Treatment of Irritability in Autism Spectrum Disorder
L. K. Fung, R. A. Libove and A. Y. Hardan
5:30 PM
125.188
188 The Effects of a Novel Vasopressin V1a Antagonist on Orienting to Biological Motion
F. Shic, M. del Valle Rubido, E. Hollander, S. S. Jeste, J. T. McCracken, L. Scahill, O. Khwaja, L. Squassante, E. S. Kim, M. G. Perlmutter, E. Sharer, R. J. Jou, M. C. Lyons, T. Apelian, G. Berlin, C. J. Ferretti, A. Gavaletz, R. L. Loomis, T. Shimizu, B. P. Taylor, C. A. Wall and D. Umbricht
5:30 PM
125.189
189 Effects of a Beta-Adrenergic Antagonist on Social and Cognitive Functioning in Autism Spectrum Disorder
R. M. Zamzow, B. J. Ferguson, M. L. Lewis, A. S. Ragsdale, J. P. Stichter and D. Q. Beversdorf
5:30 PM
125.190
190 Improving Outcome Measures for Rett Clinical Trials: The Development of Rett-Specific Anchors for the Clinical Global Impression Scales
N. E. Jones, D. G. Glaze, J. L. Neul, M. Snape, E. Anagnostou and J. Horrigan
5:30 PM
125.191
191 The Effectiveness of Methylcobalamin and Folinic Acid Treatment on Adaptive Behavior in Children with Autistic Disorder
R. E. Frye, S. Melnyk, G. J. Fuchs, T. Reid, S. L. Jernigan, O. Pavliv, A. S. Hubanks, D. Gaylor, L. Walters and S. J. James
5:30 PM
125.192
192 The Efficacy of High-Dose Folinic Acid for Autism Spectrum Disorder: A Double-Blind Placebo Controlled Study
R. E. Frye, J. C. Slattery, L. Delhey, M. Tippett, S. Melnyk, S. Rose, E. Quadros, J. M. Sequeira and S. J. James
See more of: Specific Interventions - Pharmacologic
<< Previous Session | Next Session >>

Quick Links

Connect

Public Relations

Media Registration

INSAR | 342 North Main Street West Hartford, CT 06117-2507 USA © 2012 INSAR | International Society for Autism Research